These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid. Karachalios GN. Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205 [Abstract] [Full Text] [Related]
8. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial. Khajotia RR, Vetter N, Harazin H. Clin Ther; 1991 Dec; 13(4):460-6. PubMed ID: 1933997 [Abstract] [Full Text] [Related]
11. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Kiani R, Johnson D, Nelson B. Am J Med; 1988 Sep 16; 85(3A):6-13. PubMed ID: 3048092 [Abstract] [Full Text] [Related]
14. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults]. el Filali KM, el M'Daghri N, el Kabli H, Hajji M, Benbachir M, Himmich H. Pharmatherapeutica; 1989 Sep 16; 5(5):329-37. PubMed ID: 2748691 [Abstract] [Full Text] [Related]
15. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. Cazzola M, Vinciguerra A, Beghi GF, Paizis G, Giura R, Madonini V, Fiorentini F, Consigli GF, Tonna M, Casalini A. J Chemother; 1995 Oct 16; 7(5):432-41. PubMed ID: 8596127 [Abstract] [Full Text] [Related]
16. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Clin Ther; 2006 Jan 16; 28(1):99-109. PubMed ID: 16490583 [Abstract] [Full Text] [Related]
17. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. J Antimicrob Chemother; 2004 Jan 16; 53 Suppl 1():i3-20. PubMed ID: 14726431 [Abstract] [Full Text] [Related]